Oral cavity: An open horizon for nanopharmaceuticals
Q1
Lưu vào:
Tác giả chính: | |
---|---|
Đồng tác giả: | |
Định dạng: | Bài trích |
Ngôn ngữ: | English |
Thông tin xuất bản: |
Journal of Pharmaceutical Investigation
2021
|
Chủ đề: | |
Truy cập trực tuyến: | https://link.springer.com/article/10.1007/s40005-021-00530-2 https://dlib.phenikaa-uni.edu.vn/handle/PNK/1958 https://doi.org/10.1007/s40005-021-00530-2 |
Từ khóa: |
Thêm từ khóa bạn đọc
Không có từ khóa, Hãy là người đầu tiên gắn từ khóa cho biểu ghi này!
|
id |
oai:localhost:PNK-1958 |
---|---|
record_format |
dspace |
spelling |
oai:localhost:PNK-19582022-08-17T05:54:53Z Oral cavity: An open horizon for nanopharmaceuticals Oanh Oanh Thi Nguyen Khue Dan Tran Nhan Thi Ha Sang Minh Doan Thi Thanh Hai Dinh Tuan Hiep Tran Oral cavity Nanoparticles Bioavailability Dentistry Q1 Background Oral administration is the primary route employed for drug delivery. In addition to the gastrointestinal tract, the oral cavity has been drawing considerable attention owing to its physiological properties and advances in drug carrier development. Notably, nanotechnology has made immense contributions to enhancing drug bioavailability, stability, and efficacy, both in research and clinical settings. Area covered The present review comprises lessons from physiological characteristics to fundamental material science knowledge, summarizing the pros and cons of nanotechnology applications in therapeutic drug delivery. The oral cavity presents inherent challenges, including oral cancer, dental caries, oral infection, or oral inflammation, that necessitate local solutions. Simultaneously, the vascular system under the tongue and in the buccal region offers a portal for systemic drug absorption. Expert opinion Among available delivery systems, nanoparticle-based drug delivery, with the oral cavity as the action or absorption site, can be developed as a principal dosage formulation. Although convenience and fast onset might be advantageous, additional studies are warranted for preclinical characterization, especially in animal models, and for determining manufacturing competence, prior to human trials to meet standards in clinical settings. 2021-07-06T03:10:55Z 2021-07-06T03:10:55Z 2021 Article https://link.springer.com/article/10.1007/s40005-021-00530-2 https://dlib.phenikaa-uni.edu.vn/handle/PNK/1958 https://doi.org/10.1007/s40005-021-00530-2 en application/pdf Journal of Pharmaceutical Investigation |
institution |
Trường Đại học Phenikaa |
collection |
DSpace |
language |
English |
topic |
Oral cavity Nanoparticles Bioavailability Dentistry |
spellingShingle |
Oral cavity Nanoparticles Bioavailability Dentistry Oanh Oanh Thi Nguyen Oral cavity: An open horizon for nanopharmaceuticals |
description |
Q1 |
author2 |
Khue Dan Tran |
author_facet |
Khue Dan Tran Oanh Oanh Thi Nguyen |
format |
Article |
author |
Oanh Oanh Thi Nguyen |
author_sort |
Oanh Oanh Thi Nguyen |
title |
Oral cavity: An open horizon for nanopharmaceuticals |
title_short |
Oral cavity: An open horizon for nanopharmaceuticals |
title_full |
Oral cavity: An open horizon for nanopharmaceuticals |
title_fullStr |
Oral cavity: An open horizon for nanopharmaceuticals |
title_full_unstemmed |
Oral cavity: An open horizon for nanopharmaceuticals |
title_sort |
oral cavity: an open horizon for nanopharmaceuticals |
publisher |
Journal of Pharmaceutical Investigation |
publishDate |
2021 |
url |
https://link.springer.com/article/10.1007/s40005-021-00530-2 https://dlib.phenikaa-uni.edu.vn/handle/PNK/1958 https://doi.org/10.1007/s40005-021-00530-2 |
work_keys_str_mv |
AT oanhoanhthinguyen oralcavityanopenhorizonfornanopharmaceuticals |
_version_ |
1787741075253755904 |